New Buy Thesis on Cognex Highlights Robotics, But Valuation Remains Stretched
Read source articleWhat happened
A Seeking Alpha article published on October 12, 2026, initiated a Buy rating on Cognex, citing its expanding robotics exposure through the RealSense acquisition and projected revenue growth of 15% in 2026 and 11–13% annually over the next five years. The article highlights RealSense's expected contribution of $80–90 million in 2026 and long-term growth above 25%, driven by logistics, packaging, and semiconductors. In contrast, the latest DeepValue master report maintains a WAIT rating with conviction 4.0, arguing that at $63.20 the stock already discounts broad AI-led order growth and sustained margin gains. The report notes that Cognex trades at 73.5x P/E and 48.5x EV/EBITDA, leaving little room for error, and sets an attractive entry at $52 with a re-assessment window of 3–6 months. Near-term Q2 2026 results, including revenue guidance of $280–300 million and adjusted EBITDA margin of 28%–31%, will be critical to validate the AI adoption narrative.
Implication
Investors should remain on the sidelines at the current price of $63.20, as the valuation already assumes successful AI commercialization and broad end-market strength. The Q2 2026 report due in the next few weeks is a key checkpoint: a revenue miss below $280 million or adjusted EBITDA margin below 28% would likely trigger a meaningful de-rating. Conversely, if management cites material revenue contribution from OneVision and the new In-Sight AI systems, the bull case could gain traction and justify a re-assessment. Until then, the risk/reward is unattractive; the stock has surged 87% over the past year, and sentiment appears crowded with repeated bullish media coverage. A more prudent entry would be near the $52 attractive entry level, with a stop-loss or trim above $72 if already holding.
Thesis delta
The new Seeking Alpha article does not alter the DeepValue thesis; it adds another bullish voice but fails to address the premium valuation and lack of margin of safety. The thesis remains WAIT with conviction 4.0, attractive entry $52, and trim above $72. Near-term checkpoints and monitoring triggers are unchanged.
Confidence
medium